XBiotech (XBIT) Net Shares Issued and Repurchased (2014 - 2025)
XBiotech (XBIT) posted Net Shares Issued and Repurchased of $1.4 million for Q4 2025, up 28.86% on a QoQ basis from $1.1 million in Q1 2025, and up 49.46% year-over-year from $919166.0 in Q4 2024.
Powered by 
Analysis
XBiotech (XBIT) Net Shares Issued and Repurchased (2014 - 2025) Analysis & Trends
XBiotech has reported Net Shares Issued and Repurchased for 12 years, with the latest figure at $1.4 million in Q4 2025.
- On a quarterly basis, Net Shares Issued and Repurchased rose 49.46% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 49.46% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 49.46% from the prior year.
- Net Shares Issued and Repurchased was $1.4 million for Q4 2025 at XBiotech, up from $1.1 million in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $1.4 million in Q4 2025, with the low at $31767.0 in Q1 2022.
- Average Net Shares Issued and Repurchased over 5 years is $663963.4, with a median of $754150.0 recorded in 2021.
- The sharpest annual moves came in 2022 and 2023: Net Shares Issued and Repurchased tumbled 69.07% in 2022, then soared 2099.77% in 2023.
- Over 5 years, Net Shares Issued and Repurchased stood at $809500.0 in 2021, then sank by 69.07% to $250375.0 in 2022, then jumped by 223.35% to $809600.0 in 2023, then increased by 13.53% to $919166.0 in 2024, then soared by 49.46% to $1.4 million in 2025.
- The last three Net Shares Issued and Repurchased figures came in at $1.4 million (Q4 2025), $1.1 million (Q1 2025), and $919166.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | XBiotech | 66.16 Mn | 66.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 919,166.00 |
| Mar 31, 2024 | 614,750.00 |
| Dec 31, 2023 | 809,600.00 |
| Mar 31, 2023 | 698,800.00 |
| Dec 31, 2022 | 250,375.00 |
| Mar 31, 2022 | 31,767.00 |
| Dec 31, 2021 | 809,500.00 |
| Mar 31, 2021 | 65,833.00 |
| Dec 31, 2020 | 230,500.00 |
| Mar 31, 2020 | 50,500.00 |
| Dec 31, 2019 | 2.56 Mn |
| Mar 31, 2019 | 215,000.00 |
| Dec 31, 2018 | 1.15 Mn |
| Mar 31, 2018 | 532,475.00 |
| Dec 31, 2017 | 1.25 Mn |
| Mar 31, 2017 | 27,125.00 |
| Dec 31, 2016 | 1.06 Mn |
| Sep 30, 2016 | 286,625.00 |